Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Colorimetric Method Development – V 2.0

Posted on By

Analytical Method Development: Colorimetric Method Development – V 2.0

SOP for Colorimetric Method Development in Analytical Method Development Laboratory


Department Analytical Method Development
SOP No. SOP/AMD/051/2025
Supersedes SOP/AMD/051/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

The purpose of this SOP is to outline the standardized approach for developing, optimizing, and validating colorimetric methods for the qualitative and quantitative determination of analytes in pharmaceutical substances.

Colorimetric methods use specific reagents to develop color based on chemical reactions, which is then measured spectrophotometrically to infer concentration.

2. Scope

This SOP is applicable to the Analytical Method Development (AMD) laboratory for developing colorimetric procedures for analysis of APIs, excipients, intermediates, and dosage forms where applicable, in compliance with pharmacopeial and ICH guidelines.

3. Responsibilities

  • Analytical Chemist: Responsible for developing and executing the method, selecting reagents, measuring absorbance, and recording observations.
  • Method Reviewer: Validates the accuracy and repeatability of the developed method, verifies absorbance readings and calculations.
  • QA: Ensures the method and documentation comply with GMP, ICH, and pharmacopeial requirements.
  • Head – AMD: Provides approval for final method release and oversees its incorporation into regulatory documents.

4. Accountability

The Head of the Analytical Method Development department is accountable for ensuring the suitability, reproducibility, and regulatory compliance of all colorimetric methods developed for pharmaceutical testing.

See also  Analytical Method Development: Forced Degradation Studies - V 2.0

5. Procedure

5.1 Preliminary Assessment

  1. Review available pharmacopeial and scientific literature for existing colorimetric procedures relevant to the analyte or chemical class.
  2. Assess the chemical functionality of the target analyte to identify potential reagents that produce color upon reaction.
  3. Determine the purpose of the colorimetric method:
    • Limit test (qualitative)
    • Assay or content determination (quantitative)
  4. Record findings and justification in Annexure-1: Preliminary Method Review Sheet.

5.2 Reagent Selection and Reaction Optimization

  1. Identify reagents known to form chromogenic complexes with the target analyte. Examples include:
    • 1,10-phenanthroline for iron
    • Nessler’s reagent for ammonia
    • Diphenylcarbazone for mercury
  2. Prepare multiple test solutions with varying concentrations of analyte and reagent under controlled conditions.
  3. Determine the optimal reagent-to-analyte molar ratio based on the intensity of color and reaction stability.
  4. Evaluate different reaction times, pH values, and buffer systems.
  5. Measure absorbance at multiple wavelengths to identify λmax.
  6. Document the optimized reaction conditions in Annexure-2: Optimization Worksheet.

5.3 Standard Preparation and Calibration Curve

  1. Prepare standard stock solutions of the analyte using a certified reference material (CRM).
  2. Prepare a series of dilutions (5–7 points) spanning the expected concentration range.
  3. React each dilution with the color reagent under optimized conditions.
  4. Measure absorbance at the determined λmax using a UV-Vis spectrophotometer.
  5. Plot the absorbance vs concentration to generate the calibration curve.
  6. Ensure linearity with correlation coefficient (R²) ≥ 0.999.
  7. Record data in Annexure-3: Calibration Curve Log.
See also  Analytical Method Development: UV Spectrophotometric Method Development - V 2.0

5.4 Sample Analysis

  1. Prepare test samples according to formulation or API-specific instructions (e.g., dissolution, dilution, filtration).
  2. Treat test samples with the same reagents and under identical conditions as standards.
  3. Measure the absorbance and determine analyte concentration using the calibration curve.
  4. Repeat analysis in triplicate to ensure precision.
  5. Document findings in Annexure-4: Sample Analysis Record.

5.5 Method Validation

  1. Conduct validation as per ICH Q2(R1):
  2. Specificity: Demonstrate that color development is analyte-specific and unaffected by excipients or solvents.
  3. Linearity: Confirm R² ≥ 0.999 over working range.
  4. Accuracy: Perform spike recovery studies at 80%, 100%, and 120% levels (acceptable recovery 98–102%).
  5. Precision: Determine intra-day and inter-day variability (RSD ≤ 2.0%).
  6. LOD & LOQ: Calculate based on signal-to-noise ratio of 3.3 and 10 respectively.
  7. Robustness: Vary reaction time, reagent concentration, and pH to observe stability of absorbance.
  8. Solution Stability: Test absorbance at intervals over 6 hours.
  9. Record validation data in Annexure-5: Validation Summary Report.

5.6 Final Method Documentation

  1. Prepare detailed method SOP including:
    • Objective and applicability
    • Reagent composition and preparation
    • Sample preparation instructions
    • Reaction procedure
    • Instrumentation details
    • System suitability and acceptance criteria
  2. Submit method to QA for review and approval prior to official use.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • CRM: Certified Reference Material
  • UV-Vis: Ultraviolet-Visible Spectrophotometry
  • ICH: International Council for Harmonisation
  • RSD: Relative Standard Deviation
See also  Analytical Method Development: Validation-Readiness Evaluation of Developed Methods - V 2.0

7. Documents

  1. Preliminary Method Review Sheet – Annexure-1
  2. Optimization Worksheet – Annexure-2
  3. Calibration Curve Log – Annexure-3
  4. Sample Analysis Record – Annexure-4
  5. Validation Summary Report – Annexure-5

8. References

  • USP <851> – Spectrophotometry and Light Scattering
  • ICH Q2(R1) – Validation of Analytical Procedures
  • IP, Ph. Eur., BP – General Colorimetric Tests
  • AOAC Official Methods for Colorimetric Analysis

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Preliminary Method Review Sheet

Analyte Literature Source Color Reagent Remarks Prepared By
Iron (III) USP 1,10-Phenanthroline Forms orange-red complex Rajesh Kumar

Annexure-2: Optimization Worksheet

Trial Reagent Volume (mL) pH λmax (nm) Observation
1 2.0 4.5 510 Stable complex

Annexure-3: Calibration Curve Log

Concentration (ppm) Absorbance
5 0.135
10 0.270
20 0.540
30 0.810
40 1.080

Annexure-4: Sample Analysis Record

Sample Absorbance Calculated Conc. (ppm) Analyst
API-A 0.540 20.0 Sunita Reddy

Annexure-5: Validation Summary Report

Parameter Criteria Result Status
Precision RSD ≤ 2% 1.2% Pass
Accuracy 98–102% 99.6% Pass
Linearity R² ≥ 0.999 0.9995 Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded validation, annexures and buffer optimization data Audit Preparedness
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Pre-formulation Studies of Elixirs – V 2.0
Next Post: API Manufacturing: SOP for Destruction of Used IPC Samples – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version